The roles of adenosine deaminase in autoimmune diseases
Authors:
- 1 January 2021
- journal article
- review article
- Published by Elsevier in Autoimmunity Reviews
- Vol. 20 (1) , 102709
Abstract
No abstract availableKeywords
Funding Information
- Natural Science Basic Research Program of Shaanxi Province
This publication has 41 references indexed in Scilit:
- Alterations in the cholinesterase and adenosine deaminase activities and inflammation biomarker levels in patients with multiple sclerosisNeuroscience, 2014
- The role of the adenosinergic system in lung fibrosisPharmacological Research, 2013
- Potential role of adenosine deaminase in the diagnosis of adult-onset Still’s diseaseRheumatology International, 2012
- Serum adenosine deaminase activity in patients with systemic lupus erythematosus: a study based on ADA1 and ADA2 isoenzymes patternRheumatology International, 2011
- Human plasma adenosine deaminase 2 is secreted by activated monocytesBiological Chemistry, 2006
- Gene therapy for adenosine deaminase deficiencyCurrent Opinion in Allergy and Clinical Immunology, 2003
- Serum Adenosine Deaminase and Cytidine Deaminase Activities in Patients with Systemic Lupus ErythematosusClinical Chemistry and Laboratory Medicine (CCLM), 2002
- Isozyme Analysis of the High Serum Adenosine Deaminase Activity in Patients with Myasthenia Gravis.Internal Medicine, 1995
- Serum adenosine deaminase activity in systemic sclerosis (scleroderma) and related disordersJournal of the American Academy of Dermatology, 1992
- High serum adenosine deaminase activity and its correlation with lymphocyte subsets in myasthenia gravisJournal of the Neurological Sciences, 1990